User contributions
(newest | oldest) View (newer 100 | older 100) (20 | 50 | 100 | 250 | 500)
- 16:17, 9 March 2009 (diff | hist) . . (+697) . . N European Medicines Agency (New page: ==Background== The European Medicines Agency (EMEA) is a decentralised body of the European Union with headquarters in London. Its main responsibility is the protection and promot...)
- 16:12, 9 March 2009 (diff | hist) . . (+60) . . N MHRA (New page: See Medicines and Healthcare products Regulatory Agency.) (current)
- 16:12, 9 March 2009 (diff | hist) . . (+14) . . N Selective serotonin reuptake inhibitors (New page: See SSRIs.) (current)
- 16:04, 9 March 2009 (diff | hist) . . (+47) . . m SSRIs (current)
- 16:02, 9 March 2009 (diff | hist) . . (-3,458) . . Offshore - and out of reach to the Revenue (Removing all content from page) (current)
- 15:58, 9 March 2009 (diff | hist) . . (+3,806) . . N Pharma: Tax Avoidance (New page: '''Pharma: Tax Evasion''' A report in '''The Guardian''' shows how pharmaceutical giants GlaxoSmithKline and AstraZeneca "offshore" legal ownership of their valuable trademarks to...)
- 15:46, 9 March 2009 (diff | hist) . . (-2,814) . . When is a drug deemed so 'successful' that it deserves to be pulled off a trial? (Removing all content from page) (current)
- 15:39, 9 March 2009 (diff | hist) . . (+1) . . FDA Approval Process: Political Lobbying (current)
- 15:34, 9 March 2009 (diff | hist) . . (+7,381) . . N FDA Approval Process: Political Lobbying (New page: '''FDA Approval Process: Political Lobbying''' The Food and Drug Administration (FDA) aims to protect the health of the American people. It assures the ‘safety, efficacy, and se...)
- 13:55, 9 March 2009 (diff | hist) . . (+24) . . Food and Drug Administration (→About)
- 13:55, 9 March 2009 (diff | hist) . . (+3) . . Food and Drug Administration (→About)
- 13:54, 9 March 2009 (diff | hist) . . (+709) . . Food and Drug Administration
- 13:38, 9 March 2009 (diff | hist) . . (+37) . . N FDA (New page: See Food and Drug Administration.) (current)
- 18:23, 3 March 2009 (diff | hist) . . (+1,135) . . Medicines and Healthcare products Regulatory Agency (→People)
- 17:59, 3 March 2009 (diff | hist) . . (+882) . . Medicines and Healthcare products Regulatory Agency
- 17:31, 3 March 2009 (diff | hist) . . (+33) . . Meningitis C Vaccine (→Contamination) (current)
- 16:16, 3 March 2009 (diff | hist) . . (+1,415) . . N Meningitis C Vaccine
- 15:42, 3 March 2009 (diff | hist) . . (+436) . . Industry-friendly experts (→In the Pharma field) (current)
- 22:04, 17 February 2009 (diff | hist) . . (+25) . . When is a drug deemed so 'successful' that it deserves to be pulled off a trial?
- 21:44, 17 February 2009 (diff | hist) . . (+24) . . Wyeth
- 21:43, 17 February 2009 (diff | hist) . . (+24) . . Schering-Plough
- 21:43, 17 February 2009 (diff | hist) . . (+24) . . Sanofi-Aventis Group
- 21:42, 17 February 2009 (diff | hist) . . (+24) . . Pfizer
- 21:41, 17 February 2009 (diff | hist) . . (+24) . . Novartis
- 21:41, 17 February 2009 (diff | hist) . . (-14) . . Merck and Co. Inc.
- 21:40, 17 February 2009 (diff | hist) . . (+24) . . Johnson & Johnson
- 21:39, 17 February 2009 (diff | hist) . . (+24) . . Roche
- 21:39, 17 February 2009 (diff | hist) . . (+24) . . Eli Lilly and Company
- 21:37, 17 February 2009 (diff | hist) . . (+24) . . Bristol-Myers Squibb
- 21:36, 17 February 2009 (diff | hist) . . (+24) . . AstraZeneca
- 21:35, 17 February 2009 (diff | hist) . . (+448) . . Vioxx
- 21:29, 17 February 2009 (diff | hist) . . (+24) . . Vioxx
- 21:28, 17 February 2009 (diff | hist) . . (+24) . . SSRIs
- 21:27, 17 February 2009 (diff | hist) . . (+16) . . Gardasil
- 21:26, 17 February 2009 (diff | hist) . . (+24) . . Food and Drug Administration
- 21:24, 17 February 2009 (diff | hist) . . (+25) . . GlaxoSmithKline
- 18:58, 17 February 2009 (diff | hist) . . (+116) . . N Category:Pharma
- 17:42, 12 February 2009 (diff | hist) . . (+1,044) . . N Gardasil
- 17:28, 8 February 2009 (diff | hist) . . (-54) . . Offshore - and out of reach to the Revenue (→Notes)
- 17:26, 8 February 2009 (diff | hist) . . (+79) . . Offshore - and out of reach to the Revenue (→Notes)
- 19:03, 3 February 2009 (diff | hist) . . (+3,433) . . N Offshore - and out of reach to the Revenue
- 18:02, 2 February 2009 (diff | hist) . . (+5,764) . . N MMR
- 15:51, 2 February 2009 (diff | hist) . . (+107) . . Harald zur Hausen (current)
- 13:12, 30 January 2009 (diff | hist) . . (+597) . . N The Gairdner Foundation (current)
- 13:02, 30 January 2009 (diff | hist) . . (+2,240) . . N Harald zur Hausen
- 15:17, 21 January 2009 (diff | hist) . . (-39) . . Adam Jacobs (current)
- 15:16, 21 January 2009 (diff | hist) . . (-42) . . Craig Westervelt (current)
- 13:12, 21 January 2009 (diff | hist) . . (+191) . . N Craig Westervelt
- 13:02, 21 January 2009 (diff | hist) . . (+146) . . N Adam Jacobs
- 23:25, 19 January 2009 (diff | hist) . . (-1) . . Industry-friendly experts (→In the Pharma field)
- 23:22, 19 January 2009 (diff | hist) . . (+16) . . Industry-friendly experts
- 23:17, 19 January 2009 (diff | hist) . . (+4,987) . . Industry-friendly experts
- 19:37, 11 January 2009 (diff | hist) . . (+27,029) . . N SSRIs
- 22:02, 11 December 2008 (diff | hist) . . (+5,341) . . N Vioxx
- 11:47, 10 December 2008 (diff | hist) . . (+30) . . When is a drug deemed so 'successful' that it deserves to be pulled off a trial?
- 11:45, 10 December 2008 (diff | hist) . . (+200) . . When is a drug deemed so 'successful' that it deserves to be pulled off a trial?
- 11:35, 10 December 2008 (diff | hist) . . (+2,559) . . N When is a drug deemed so 'successful' that it deserves to be pulled off a trial?
- 22:45, 24 November 2008 (diff | hist) . . (+11,484) . . N Chartered Institute of Public Relations Scotland
- 15:08, 24 February 2008 (diff | hist) . . (0) . . CBI: eBusiness, Data Protection and ID Cards (→eBusiness)
- 15:08, 24 February 2008 (diff | hist) . . (-9) . . CBI: eBusiness, Data Protection and ID Cards (→eBusiness)
- 15:07, 24 February 2008 (diff | hist) . . (+8) . . CBI: eBusiness, Data Protection and ID Cards (→eBusiness)
- 15:06, 24 February 2008 (diff | hist) . . (0) . . CBI: eBusiness, Data Protection and ID Cards (→eBusiness)
- 15:05, 24 February 2008 (diff | hist) . . (+234) . . CBI: eBusiness, Data Protection and ID Cards (→eBusiness)
- 14:53, 24 February 2008 (diff | hist) . . (+26) . . Business Industry Advisory Committee
- 14:52, 24 February 2008 (diff | hist) . . (+48) . . Business Industry Advisory Committee
- 14:49, 24 February 2008 (diff | hist) . . (+623) . . N Business Industry Advisory Committee
- 14:41, 24 February 2008 (diff | hist) . . (+1) . . CBI: eBusiness, Data Protection and ID Cards (→eBusiness)
- 14:41, 24 February 2008 (diff | hist) . . (+3) . . CBI: eBusiness, Data Protection and ID Cards (→eBusiness)
- 14:40, 24 February 2008 (diff | hist) . . (+131) . . CBI: eBusiness, Data Protection and ID Cards (→eBusiness)
- 14:32, 24 February 2008 (diff | hist) . . (+275) . . CBI: eBusiness, Data Protection and ID Cards (→eBusiness)
- 14:13, 24 February 2008 (diff | hist) . . (+3) . . CBI: eBusiness, Data Protection and ID Cards (→Data Protection)
- 14:13, 24 February 2008 (diff | hist) . . (+884) . . CBI: eBusiness, Data Protection and ID Cards (→Data Protection)
- 14:01, 24 February 2008 (diff | hist) . . (-8) . . CBI: eBusiness, Data Protection and ID Cards (→Data Protection)
- 13:55, 24 February 2008 (diff | hist) . . (+494) . . CBI: eBusiness, Data Protection and ID Cards (→ID Cards)
- 15:14, 23 February 2008 (diff | hist) . . (+65) . . CBI: eBusiness, Data Protection and ID Cards
- 15:11, 23 February 2008 (diff | hist) . . (+1,441) . . CBI: eBusiness, Data Protection and ID Cards
- 14:50, 23 February 2008 (diff | hist) . . (+2,717) . . N CBI: eBusiness, Data Protection and ID Cards
- 14:50, 23 February 2008 (diff | hist) . . (0) . . Confederation of British Industry (→Resources)
- 14:50, 23 February 2008 (diff | hist) . . (+2,717) . . N CBI: eBusiness, data protection and ID Cards (current)
- 14:49, 23 February 2008 (diff | hist) . . (+28) . . Confederation of British Industry (→Resources)
- 14:28, 23 February 2008 (diff | hist) . . (+25) . . Jeremy Beale
- 14:27, 23 February 2008 (diff | hist) . . (+154) . . Jeremy Beale
- 14:24, 23 February 2008 (diff | hist) . . (+725) . . N Jeremy Beale
- 14:13, 23 February 2008 (diff | hist) . . (-1) . . CBI and ID Cards (current)
- 14:05, 23 February 2008 (diff | hist) . . (+1,387) . . CBI and ID Cards
- 13:51, 23 February 2008 (diff | hist) . . (-1) . . Confederation of British Industry (→Resources)
- 13:51, 23 February 2008 (diff | hist) . . (+1) . . Confederation of British Industry (→Resources)
- 13:48, 23 February 2008 (diff | hist) . . (-1) . . CBI and ID Cards
- 13:48, 23 February 2008 (diff | hist) . . (-35) . . CBI and ID Cards
- 11:33, 6 February 2008 (diff | hist) . . (+24) . . Confederation of British Industry (→Further Reading)
- 11:32, 6 February 2008 (diff | hist) . . (+36) . . Confederation of British Industry (→External links)
- 11:58, 30 January 2008 (diff | hist) . . (+145) . . Policy Institute (→People)
- 11:54, 30 January 2008 (diff | hist) . . (+8) . . Policy Institute (→People)
- 11:53, 30 January 2008 (diff | hist) . . (+15) . . Policy Institute (→People)
- 11:50, 30 January 2008 (diff | hist) . . (+10) . . Policy Institute
- 11:48, 30 January 2008 (diff | hist) . . (-3) . . Policy Institute
- 11:46, 30 January 2008 (diff | hist) . . (-3) . . Policy Institute (→Prof. Peter Jones;)
- 11:45, 30 January 2008 (diff | hist) . . (+5) . . Policy Institute
- 11:42, 30 January 2008 (diff | hist) . . (+145) . . Policy Institute
- 11:24, 30 January 2008 (diff | hist) . . (+39) . . Stockholm Network (→Members)
(newest | oldest) View (newer 100 | older 100) (20 | 50 | 100 | 250 | 500)